Home
Search

Press Releases

Get the latest on BIO’s announcements, positions, and views.

Featured Press Releases
BIO Statement on Veto of Prescription Drug…
Patrick J. Plues, Senior Vice President of State Government Affairs & Affiliate Relations at the Biotechnology Innovation Organization (BIO) released the following statement on the veto of Prescription Drug Affordability Boards (PDAB)…
Learn more
BIO Statement on Resignation of FDA Commissioner…
WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), released the following statement on the resignation of FDA Commissioner Marty Makary.“Dr. Makary inherited an FDA in crisis after the DOGE…
Learn more
BIO Launches “The Fight of Our Lives,” a National…
WASHINGTON, DC – Today, the Biotechnology Innovation Organization (BIO) announced the launch of ​​The Fight of Our Lives, a new national campaign focused on the stories behind biotechnology breakthroughs, the patients whose lives depend on them…
Learn more
All Press Releases
  • Show All
Search
Results
Event Tags
BIO Welcomes EPA’s Final 2017 Renewable Fuel Standards
November 23, 2016
The Environmental Protection Agency’s final Renewable Fuel Standards for 2017 and biomass-based diesel volume for 2018 appear to put the program back on track and will provide considerable additional certainty for investors in advanced and…
BIO Statement on FDA Product Communications Hearing
November 9, 2016
BIO President and CEO Jim Greenwood released the following statement today regarding the FDA’s hearing on product communications:“In the era of data-driven medicine, where all parties seek more, not less, information about the safety,…
BIO Patient and Health Advocacy Summit Hosts Over 300 Attendees from Wide Range of Health Care Organizations
November 4, 2016
Over 200 diverse groups were represented at the November 3-4 meeting in Washington, D.C.
BIO Issues Call for Papers for 2017 World Congress on Industrial Biotechnology in Montréal
November 1, 2016
BIO has officially issued a call to leaders from the biotechnology, bioenergy, chemical, consumer products manufacturing, and agricultural industries as well as academia and financial sectors industries to submit panel session proposals for the…
BIO Asks Congress to Extend Critical Bioenergy Tax Credits During Lame-Duck
October 18, 2016
BIO today sent a letter to Congressional Leadership, the Senate Finance Committee Chairs, and the House Ways and Means Committee Chairs calling for the extension of renewable energy tax credits slated to expire at the end of 2016. In its letter…
BIO Names Dana O’Brien Executive Vice President for Food & Agriculture Section
October 13, 2016
BIO announced today that Dana O’Brien has been named BIO’s Executive Vice President for its Food & Agriculture Section.
New BIO Report Dispels the Myth of the Blend Wall and High RIN Prices
October 4, 2016
Data recently released by EPA on compliance with the Renewable Fuel Standard between 2010 and 2013 (the latest year for which compliance is complete) challenges the widely accepted assumption that the blend wall – the point at which ethanol blending…
BIO Statement on Biosimilar User Fee Act Goals Letter
September 26, 2016
Washington, D.C. (September 16, 2016) – Biotechnology Innovation Organization (BIO) Senior Vice President for Science Policy Kay Holcombe released the following statement today regarding the Biosimilar User Fee Act (BsUFA) II goals letter:
BIO Applauds Senate Passage of Advancing Hope Act
September 23, 2016
Washington, D.C. (September 23, 2016) – Biotechnology Innovation Organization (BIO) President and CEO Jim Greenwood released the following statement today regarding Senate passage of the Advancing Hope Act of 2016:
BIO Statement Regarding the UN High Level Panel on Access to Medicines Report
September 14, 2016
Sadly the United Nations High Level Panel ignored the real issues that impact or delay delivery of innovative treatments and cures throughout the developing world, while focusing on policy recommendations in the one area –…